Enhertu wins EU approval for adjuvant HER2-positive early breast cancerOct 27Regulatory decisionAstraZenecaDaiichi Sankyo
CHMP backs two AstraZeneca drugs: Klygefa in gMG, Enhertu in early breast cancerSep 21Regulatory milestoneAstraZenecafam-trastuzumab deruxtecan-nxki